Applied DNA Sciences 주식 주식분석 | 주식가격 | 뉴스 | APDN | US03815U3005 | A2PUTA

날짜	Applied DNA Sciences 주식 가격
	0.23 undefined
	0.18 undefined
	0.16 undefined
	0.22 undefined
	0.22 undefined
	0.20 undefined
	0.20 undefined
	0.17 undefined
	0.16 undefined
	0.18 undefined
	0.20 undefined
	0.15 undefined
	0.15 undefined
	0.15 undefined
	0.16 undefined
	0.16 undefined
	0.16 undefined
	0.16 undefined
	0.17 undefined
	0.17 undefined

날짜	Applied DNA Sciences 매출	Applied DNA Sciences EBIT	Applied DNA Sciences 이익
2025e	5.31 백만 undefined	-13.43 백만 undefined	-10.98 백만 undefined
2024e	3.59 백만 undefined	-14.54 백만 undefined	-72.7 백만 undefined
2023	13.37 백만 undefined	-10.95 백만 undefined	-9.95 백만 undefined
2022	18.17 백만 undefined	-13.97 백만 undefined	-8.38 백만 undefined
2021	9.03 백만 undefined	-12.29 백만 undefined	-14.29 백만 undefined
2020	1.93 백만 undefined	-12.54 백만 undefined	-13.03 백만 undefined
2019	5.39 백만 undefined	-9.13 백만 undefined	-8.93 백만 undefined
2018	3.9 백만 undefined	-11.65 백만 undefined	-11.69 백만 undefined
2017	4.75 백만 undefined	-12.82 백만 undefined	-12.86 백만 undefined
2016	4.19 백만 undefined	-12.2 백만 undefined	-12.18 백만 undefined
2015	9.01 백만 undefined	-7.85 백만 undefined	-11.88 백만 undefined
2014	2.72 백만 undefined	-12.27 백만 undefined	-13.07 백만 undefined
2013	2.04 백만 undefined	-10.18 백만 undefined	-17.69 백만 undefined
2012	1.86 백만 undefined	-6.51 백만 undefined	-7.15 백만 undefined
2011	969,000 undefined	-8.06 백만 undefined	-10.52 백만 undefined
2010	520,000 undefined	-7.12 백만 undefined	-7.91 백만 undefined
2009	295,000 undefined	-6.9 백만 undefined	3.95 백만 undefined
2008	873,000 undefined	-4.16 백만 undefined	-6.8 백만 undefined
2007	122,000 undefined	-12.54 백만 undefined	-13.31 백만 undefined
2006	19,000 undefined	-10.05 백만 undefined	-2.41 백만 undefined
2005	0 undefined	-51.71 백만 undefined	-67.11 백만 undefined
2004	0 undefined	-17.58 백만 undefined	-19.36 백만 undefined

	매출	EBIT	이익
2004	0 USD	-17.58 백만 USD	-19.36 백만 USD
2005	0 USD	-51.71 백만 USD	-67.11 백만 USD
2006	19,000 USD	-10.05 백만 USD	-2.41 백만 USD
2007	122,000 USD	-12.54 백만 USD	-13.31 백만 USD
2008	873,000 USD	-4.16 백만 USD	-6.8 백만 USD
2009	295,000 USD	-6.9 백만 USD	3.95 백만 USD
2010	520,000 USD	-7.12 백만 USD	-7.91 백만 USD
2011	969,000 USD	-8.06 백만 USD	-10.52 백만 USD
2012	1.86 백만 USD	-6.51 백만 USD	-7.15 백만 USD
2013	2.04 백만 USD	-10.18 백만 USD	-17.69 백만 USD
2014	2.72 백만 USD	-12.27 백만 USD	-13.07 백만 USD
2015	9.01 백만 USD	-7.85 백만 USD	-11.88 백만 USD
2016	4.19 백만 USD	-12.2 백만 USD	-12.18 백만 USD
2017	4.75 백만 USD	-12.82 백만 USD	-12.86 백만 USD
2018	3.9 백만 USD	-11.65 백만 USD	-11.69 백만 USD
2019	5.39 백만 USD	-9.13 백만 USD	-8.93 백만 USD
2020	1.93 백만 USD	-12.54 백만 USD	-13.03 백만 USD
2021	9.03 백만 USD	-12.29 백만 USD	-14.29 백만 USD
2022	18.17 백만 USD	-13.97 백만 USD	-8.38 백만 USD
2023	13.37 백만 USD	-10.95 백만 USD	-9.95 백만 USD
2024e	3.59 백만 USD	-14.54 백만 USD	-72.7 백만 USD
2025e	5.31 백만 USD	-13.43 백만 USD	-10.98 백만 USD

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0	0.03	1.23	0.03	0.14	0.21	0.02	2.75	0.73	6.36	1.39	7.31	4.48	2.96	1.66	0.56	7.79	6.56	15.22	7.15
0	0.01	0.01	0	0.08	0.05	0.06	0.21	0.3	0.67	0.84	3.93	6.38	2.59	1.49	0.84	0.19	2.8	3.07	0.26
0	0	8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0.3	0.33	0.22	0.14	0.5	1.37	0.6	0.33
0	0	0.11	0.5	0.08	0.08	0.16	0.08	0.08	0.17	0.14	0.29	0.2	0.37	0.64	0.61	0.6	0.57	1.06	0.39
0	0.04	1.35	0.53	0.29	0.34	0.24	3.03	1.1	7.21	2.36	11.54	11.35	6.24	4	2.15	9.08	11.3	19.94	8.13
0.03	0.01	0.16	0.11	0.06	0.01	0	0.09	0.21	0.7	0.58	0.57	0.79	0.52	0.42	0.23	1.28	3.02	2.22	2.08
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	1.5	1.54	0	0	0	0	0	0	0
0.03	9.12	2.11	1.74	1.37	1	0.64	0.27	0	0.42	0.33	1.6	1.53	1.04	0.86	0.74	0.61	0	0	2.7
0	0	0	0	0	0	0	0	0	0	0	285	285	285	285	285	285	0	0	0
0.02	0.01	1.06	0.04	0.12	0.16	0.53	0.11	0.04	0.05	0.24	0.06	0.08	0.06	0.06	0.17	0.1	0.1	0.1	0.75
0.08	9.14	3.33	1.89	1.55	1.17	1.17	0.47	0.25	1.17	1.14	4.02	4.21	1.91	1.63	1.42	2.26	3.12	2.32	5.53
0.08	9.18	4.68	2.41	1.85	1.51	1.41	3.5	1.35	8.38	3.51	15.55	15.57	8.15	5.63	3.57	11.34	14.42	22.27	13.65

11.99	0.11	0.12	0.18	0.21	0.28	0.35	0.47	0.65	0.79	0.01	0.02	0.02	0.03	0.03	0	0.01	0.01	0.01	0.01
6.12	82.34	82.63	128.45	133.13	141.41	149.4	160.39	169.12	190.52	198.28	224.19	234.16	243.5	249.09	255.96	275.55	295.23	305.4	307.39
-22.82	-89.93	-92.34	-140.57	-147.38	-143.43	-151.34	-161.86	-169.01	-186.69	-199.76	-211.64	-223.82	-236.67	-248.37	-256.81	-269.84	-284.12	-292.5	-302.45
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-4.71	-7.47	-9.59	-11.94	-14.04	-1.75	-1.6	-0.99	0.76	4.62	-1.47	12.57	10.37	6.86	0.75	-0.84	5.72	11.11	12.91	4.95
1.88	0.35	0.34	1.23	0.41	0.59	0.72	0.17	0.47	0.64	1.06	1.24	1.53	0.38	0.5	1.15	1.25	2.01	1.74	1.07
0.12	2.22	5.23	11.98	12.41	0.25	0.25	0.6	0.12	0.33	0.44	1.15	0.72	0.56	0.46	0.45	0.68	0.98	1.88	1.7
0	0	0	0.4	0	0	0.05	0	0	0.15	0.58	0.28	1.84	0.35	1.86	0.64	0.51	0.28	0.56	0.08
1.16	0.41	0.41	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1.63	0	3.76	0.74	3.06	2.41	1.77	3.73	0	0	1.8	0	0	0	0	0	1.83	0	0	0
4.79	2.98	9.73	14.36	15.88	3.25	2.79	4.5	0.59	1.12	3.88	2.67	4.09	1.3	2.82	2.25	4.27	3.27	4.19	2.85
0	0	4.53	0	0	0	0.22	0	0	0	0	0	0	0	1.59	1.55	0.52	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	684
0	13.67	0	0	0	0	0	0	0	2.64	1.1	0.32	1.12	0	0.47	0.62	0.85	0.03	5.17	5.25
0	13.67	4.53	0	0	0	0.22	0	0	2.64	1.1	0.32	1.12	0	2.06	2.17	1.37	0.03	5.17	5.93
4.79	16.65	14.26	14.36	15.88	3.25	3.01	4.5	0.59	3.76	4.97	2.99	5.2	1.3	4.88	4.41	5.63	3.3	9.36	8.78
0.08	9.18	4.68	2.41	1.85	1.51	1.41	3.5	1.35	8.38	3.51	15.56	15.57	8.15	5.63	3.57	11.35	14.42	22.27	13.73

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
-19	-67	-2	-13	-6	3	-7	-10	-7	-17	-13	-11	-12	-12	-11	-8	-13	-14	-8	-10
0	0	1,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1,000	1,000
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
1	0	2	8	0	0	0	0	0	0	0	-3	0	0	2	0	0	-3	0	2
14	57	-4	2	3	-7	4	6	2	9	3	8	2	3	1	0	1	3	-2	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
-3	-9	-2	-2	-2	-2	-2	-3	-3	-7	-8	-6	-9	-7	-6	-6	-11	-13	-8	-6
0	0	0	0	0	0	0	0	0	-1	0	-2	0	0	0	0	-1	-2	0	-1
0	0	0	0	0	0	0	0	0	-1	0	-2	0	0	0	0	-1	-2	0	-1
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
2	0	4	1	2	2	2	1	0	0	1	0	0	0	1	1	0	-1	0	0
0	9	0	0	0	0	0	4	2	14	2	15	7	6	4	3	18	16	18	0
2	9	4	1	2	2	2	6	2	14	3	15	7	6	5	5	19	14	18	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	1	-1	0	0	0	2	-2	5	-4	5	-2	-1	-1	-1	7	-1	8	-7
-3.12	-9.14	-3.06	-2.26	-2.95	-2.47	-2.46	-3.85	-4.12	-9.09	-8.74	-9.11	-10.69	-7.63	-7.19	-6.93	-12.2	-15.94	-9.47	-7.36
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Applied DNA Sciences 브루토마진	Applied DNA Sciences 이익 마진	Applied DNA Sciences EBIT-마진	Applied DNA Sciences 이익 마진
2025e	41.39 %	-252.98 %	-206.8 %
2024e	41.39 %	-405.38 %	-2,026.81 %
2023	41.39 %	-81.94 %	-74.41 %
2022	27.82 %	-76.89 %	-46.11 %
2021	54.59 %	-136.17 %	-158.24 %
2020	62.68 %	-648.81 %	-674.43 %
2019	83.71 %	-169.33 %	-165.76 %
2018	69.1 %	-298.39 %	-299.59 %
2017	77.33 %	-269.84 %	-270.6 %
2016	82.18 %	-291.45 %	-290.87 %
2015	41.39 %	-87.18 %	-131.88 %
2014	41.39 %	-451.01 %	-480.23 %
2013	41.39 %	-499.8 %	-868.66 %
2012	41.39 %	-350.84 %	-385.5 %
2011	41.39 %	-831.37 %	-1,085.14 %
2010	41.39 %	-1,368.65 %	-1,521.15 %
2009	79.32 %	-2,337.63 %	1,337.29 %
2008	80.41 %	-475.95 %	-779.15 %
2007	81.15 %	-10,279.51 %	-10,905.74 %
2006	15.79 %	-52,894.74 %	-12,684.21 %
2005	41.39 %	0 %	0 %
2004	41.39 %	0 %	0 %

	브루토마진	EBIT-마진	이익 마진
2004	41.39 %	0 %	0 %
2005	41.39 %	0 %	0 %
2006	15.79 %	-52,894.74 %	-12,684.21 %
2007	81.15 %	-10,279.51 %	-10,905.74 %
2008	80.41 %	-475.95 %	-779.15 %
2009	79.32 %	-2,337.63 %	1,337.29 %
2010	41.39 %	-1,368.65 %	-1,521.15 %
2011	41.39 %	-831.37 %	-1,085.14 %
2012	41.39 %	-350.84 %	-385.5 %
2013	41.39 %	-499.8 %	-868.66 %
2014	41.39 %	-451.01 %	-480.23 %
2015	41.39 %	-87.18 %	-131.88 %
2016	82.18 %	-291.45 %	-290.87 %
2017	77.33 %	-269.84 %	-270.6 %
2018	69.1 %	-298.39 %	-299.59 %
2019	83.71 %	-169.33 %	-165.76 %
2020	62.68 %	-648.81 %	-674.43 %
2021	54.59 %	-136.17 %	-158.24 %
2022	27.82 %	-76.89 %	-46.11 %
2023	41.39 %	-81.94 %	-74.41 %
2024e	41.39 %	-405.38 %	-2,026.81 %
2025e	41.39 %	-252.98 %	-206.8 %

날짜	Applied DNA Sciences 주당 매출	Applied DNA Sciences EBIT 당 주식	Applied DNA Sciences 주당 이익
2025e	0.52 undefined	0 undefined	-1.07 undefined
2024e	0.35 undefined	0 undefined	-7.06 undefined
2023	20.44 undefined	-16.75 undefined	-15.21 undefined
2022	40.56 undefined	-31.18 undefined	-18.7 undefined
2021	26.09 undefined	-35.53 undefined	-41.29 undefined
2020	9.86 undefined	-63.95 undefined	-66.48 undefined
2019	117.15 undefined	-198.37 undefined	-194.2 undefined
2018	105.49 undefined	-314.76 undefined	-316.03 undefined
2017	143.97 undefined	-388.48 undefined	-389.58 undefined
2016	139.53 undefined	-406.67 undefined	-405.87 undefined
2015	375.38 undefined	-327.25 undefined	-495.04 undefined
2014	160.06 undefined	-721.88 undefined	-768.65 undefined
2013	135.73 undefined	-678.4 undefined	-1,179.07 undefined
2012	154.58 undefined	-542.33 undefined	-595.92 undefined
2011	121.12 undefined	-1,007 undefined	-1,314.38 undefined
2010	86.67 undefined	-1,186.17 undefined	-1,318.33 undefined
2009	49.17 undefined	-1,149.33 undefined	657.5 undefined
2008	218.25 undefined	-1,038.75 undefined	-1,700.5 undefined
2007	40.67 undefined	-4,180.33 undefined	-4,435 undefined
2006	9.5 undefined	-5,025 undefined	-1,205 undefined
2005	0 undefined	-51,709 undefined	-67,110 undefined
2004	0 undefined	0 undefined	0 undefined

	주당 매출	EBIT 당 주식	주당 이익
2004	0 USD	0 USD	0 USD
2005	0 USD	-51,709 USD	-67,110 USD
2006	9.5 USD	-5,025 USD	-1,205 USD
2007	40.67 USD	-4,180.33 USD	-4,435 USD
2008	218.25 USD	-1,038.75 USD	-1,700.5 USD
2009	49.17 USD	-1,149.33 USD	657.5 USD
2010	86.67 USD	-1,186.17 USD	-1,318.33 USD
2011	121.12 USD	-1,007 USD	-1,314.38 USD
2012	154.58 USD	-542.33 USD	-595.92 USD
2013	135.73 USD	-678.4 USD	-1,179.07 USD
2014	160.06 USD	-721.88 USD	-768.65 USD
2015	375.38 USD	-327.25 USD	-495.04 USD
2016	139.53 USD	-406.67 USD	-405.87 USD
2017	143.97 USD	-388.48 USD	-389.58 USD
2018	105.49 USD	-314.76 USD	-316.03 USD
2019	117.15 USD	-198.37 USD	-194.2 USD
2020	9.86 USD	-63.95 USD	-66.48 USD
2021	26.09 USD	-35.53 USD	-41.29 USD
2022	40.56 USD	-31.18 USD	-18.7 USD
2023	20.44 USD	-16.75 USD	-15.21 USD
2024e	0.35 USD	0 USD	-7.06 USD
2025e	0.52 USD	0 USD	-1.07 USD

Segmente	2019	2018
Service	3.4 백만 UNIT12	2.08 백만 UNIT12
Product	2.9 백만 UNIT12	1.83 백만 UNIT12

	Service	Product
2018	2.08 백만 USD	1.83 백만 USD
2019	3.4 백만 USD	2.9 백만 USD

날짜	Asia And Other	Europe	United States
2018	757,722 USD	1 백만 USD	2.14 백만 USD

	Asia And Other	Europe	United States
2018	757,722 USD	1 백만 USD	2.14 백만 USD

	주식 수량
2004	0 Aktien
2005	1,000 Aktien
2006	2,000 Aktien
2007	3,000 Aktien
2008	4,000 Aktien
2009	6,000 Aktien
2010	6,000 Aktien
2011	8,000 Aktien
2012	12,000 Aktien
2013	15,000 Aktien
2014	17,000 Aktien
2015	24,000 Aktien
2016	30,000 Aktien
2017	33,000 Aktien
2018	37,000 Aktien
2019	46,000 Aktien
2020	196,000 Aktien
2021	346,000 Aktien
2022	448,000 Aktien
2023	654,000 Aktien
2024e	654,000 Aktien
2025e	654,000 Aktien

EPS-예상치	EPS-실제	보고 분기
-0.36	0.47 (231.65 %)	2024 Q3
-4.59	-5.31 (-15.69 %)	2024 Q2
-6.32	-1.8 (71.54 %)	2024 Q1
-5.51	-5.2 (5.59 %)	2023 Q4
-4.9	-4.8 (1.96 %)	2023 Q3
-4.08	1 (124.51 %)	2023 Q2
-5.92	-6 (-1.42 %)	2023 Q1
-5.3	-0.2 (96.23 %)	2022 Q4
-7.24	-2.6 (64.1 %)	2022 Q3
-6.8	-4.6 (32.35 %)	2022 Q2
-5.44	-12.6 (-131.61 %)	2022 Q1
-7.62	-12.04 (-58.09 %)	2021 Q4
-5.37	-9.2 (-71.26 %)	2021 Q3
-4.35	-6.6 (-51.66 %)	2021 Q2
-11.02	-11.2 (-1.67 %)	2021 Q1
-10.61	-15.6 (-47.06 %)	2020 Q4
-13.77	-14.4 (-4.58 %)	2020 Q3
-15.71	-15.8 (-0.59 %)	2020 Q2
-25.3	-22.4 (11.45 %)	2020 Q1
-25.7	-52.6 (-104.64 %)	2019 Q4
-20.4	-32 (-56.86 %)	2019 Q3
-73.44	-64 (12.85 %)	2019 Q2
-65.28	-88 (-34.8 %)	2019 Q1
-28.56	-96 (-236.13 %)	2018 Q4
-40.8	-80 (-96.08 %)	2018 Q3
-97.92	-56 (42.81 %)	2018 Q2
-89.76	-96 (-6.95 %)	2018 Q1
-73.44	-80 (-8.93 %)	2017 Q4
-57.12	-80 (-40.06 %)	2017 Q3
-106.08	-104 (1.96 %)	2017 Q2
-48.96	-128 (-161.44 %)	2017 Q1
-73.44	-80 (-8.93 %)	2016 Q4
-89.76	-112 (-24.78 %)	2016 Q3
-89.76	-112 (-24.78 %)	2016 Q2
-73.44	-104 (-41.61 %)	2016 Q1
-73.44	-16 (78.21 %)	2015 Q4
-106.08	-64 (39.67 %)	2015 Q3
-114.24	-88 (22.97 %)	2015 Q2
-106.08	-360 (-239.37 %)	2015 Q1
-489.6	-480 (1.96 %)	2011 Q2
0	0 (0 %)	2011 Q1
-489.6	-480 (1.96 %)	2010 Q4

%-지분	이름	주식	변경
9.70874 %	AMH Equity, Ltd.	1,000,000	1,000,000
1.04854 %	L1 Capital Global Opportunities Master Fund Ltd.	108,000	108,000
1.04854 %	S.H.N. Financial Investments Ltd	108,000	108,000
0.83643 %	Altium Capital Management LP	86,152	86,152
0.80913 %	Grossman (Bruce)	83,340	83,340
0.68411 %	Sabby Management, LLC	70,463	70,463
0.19379 %	Baader Bank AG	19,960	19,960
0.18467 %	Virtu Americas LLC	19,021	19,021
0.09962 %	XTX Markets LLC	10,261	10,261
0.06514 %	Hayward (James A)	6,709	0
0.04918 %	BlackRock Institutional Trust Company, N.A.	5,066	1
0.04772 %	Concept Asset Management	4,915	0
0.03950 %	Tower Research Capital LLC	4,069	3,943
0.03826 %	Morgan Stanley & Co. LLC	3,941	3,941
0.02717 %	Shorrock (Clay)	2,798	0
0.02269 %	Murrah (Judith)	2,337	0
0.01990 %	Jantzen (Beth M)	2,050	0
0.00971 %	Nordwand Advisors, LLC	1,000	1,000
0.00657 %	Ostrum Asset Management	677	1
0.00615 %	Belvedere Trading, LLC	633	633
0.00137 %	Wells Fargo Advisors	141	0
0.00098 %	Activest Wealth Management LLC	101	101
0.00097 %	Provence Wealth Management Group	100	0
0.00094 %	Catell (Robert B)	97	0
0.00083 %	RBC Dominion Securities, Inc.	85	0
0.00077 %	Shamash (Yacov A)	79	0
0.00074 %	UBS Financial Services, Inc.	76	-284
0.00038 %	Schmalz (Elizabeth M.)	39	0
0.00033 %	Morgan Stanley Smith Barney LLC	34	1
0.00029 %	BofA Global Research (US)	30	0
0.00027 %	Ceccoli (Joseph D)	28	0
0.00024 %	Fidelity Management & Research Company LLC	25	13
0.00004 %	Simon (Sanford Rush)	4	0
0.00002 %	Osaic Holdings, Inc.	2	2
0.00001 %	ORG Partners LLC	1	1
0.00001 %	Dakota Community Bank & Trust NA	1	1
0 %	GrandView Asset Management LLC	0	-527
0 %	Moisand Fitzgerald Tamayo, LLC	0	-100
0 %	Simplex Trading, LLC	0	-24
0 %	HRT Financial LP	0	-2,726
0 %	Ground Swell Capital, LLC	0	-15,250
0 %	NewSquare Capital LLC	0	-4
0 %	Armistice Capital LLC	0	-64,800
0 %	Creative Planning, Inc.	0	-523
0 %	The Mather Group, LLC	0	-700
0 %	Cutler Group, LP	0	-140
0 %	Jane Street Capital, L.L.C.	0	-2,112
0 %	Susquehanna International Group, LLP	0	-3,618
0 %	Geode Capital Management, L.L.C.	0	-6,959
0 %	Two Sigma Investments, LP	0	-785
0 %	Ancora Advisors, L.L.C.	0	-5
0 %	Millennium Management LLC	0	-989
0 %	Citadel Advisors LLC	0	-395
0 %	AWM Investment Company, Inc.	0	-40,440
0 %	H. M. Payson & Co.	0	-770
0 %	The Vanguard Group, Inc.	0	-8,799
0 %	Wells Fargo Bank, N.A.	0	-7
0 %	State Street Global Advisors (US)	0	-3,784
0 %	Raymond James & Associates, Inc.	0	-2,494
0 %	Goldman Sachs & Company, Inc.	0	-607
0 %	U.S. Bancorp Asset Management, Inc.	0	-25
0 %	Northern Trust Investments, Inc.	0	-790
0 %	J.P. Morgan Securities LLC	0	-1
0 %	Glen Eagle Advisors, LLC	0	-3
0 %	Silverberg Bernstein Capital Management, LLC	0	-4,915
0 %	Atria Wealth Solutions, Inc.	0	-4,051
0 %	Foundations Investment Advisors, LLC	0	-868

이름	관계	이주간 상관관계	원월 상관관계	삼개월 상관계수	여섯달 상관관계	일년간 상관관계	이년 상관관계
Himatsingka Seide	공급업체고객	0,88	0,91	0,84	0,76	0,51	-0,49
Eurofins Scientific	공급업체고객	0,75	0,87	-0,31	0,78	0,58	-0,48
Danaher	공급업체고객	0,59	0,85	0,22	0,81	0,28	-0,60
Reliance Industries	공급업체고객	-0,15	-0,79	-0,73	-0,40	-0,55	-0,67
Flora Growth	공급업체고객	-0,15	0,70	0,52	0,40	0,58
Cie Financiere Richemont	공급업체고객	-0,32	0,58	0,71	0,87	-0,20	-0,69
Tyme Technologies	공급업체고객	-0,50	-0,11	-0,09	0,93	0,91	0,81
TruTrace Technologies	공급업체고객	-0,85	-0,79	-0,81	-0,85	-0,65	-0,41
GHCL	공급업체고객	-0,89	-0,89	-0,75	-0,78	-0,79	-0,82

What values and corporate philosophy does Applied DNA Sciences represent?

Applied DNA Sciences Inc represents a set of core values and a corporate philosophy that emphasizes innovation, integrity, and sustainability. With a focus on creating DNA-based solutions, the company is committed to advancing technology for authentication, supply chain security, and anti-counterfeiting measures. Applied DNA Sciences Inc aims to provide industries with reliable, traceable, and secure solutions that protect products, brands, and intellectual property. By incorporating DNA technologies into various sectors, the company strives to promote transparency, ethical practices, and sustainability. Applied DNA Sciences Inc's dedication to scientific excellence and its global partnerships allows it to deliver cutting-edge solutions tailored to meet the unique needs of its customers in different industries.

In which countries and regions is Applied DNA Sciences primarily present?

Applied DNA Sciences Inc is primarily present in the United States. As a leading provider of DNA-based authentication solutions, Applied DNA Sciences Inc operates across various industries, including textiles, pharmaceuticals, and cannabis. With its headquarters in Stony Brook, New York, the company serves clients both domestically and internationally. While its presence expands across the globe, Applied DNA Sciences Inc focuses primarily on the United States market, where it leverages its innovative technologies to combat counterfeiting and enhance supply chain security.

What significant milestones has the company Applied DNA Sciences achieved?

Applied DNA Sciences Inc has achieved several significant milestones. One notable achievement was the successful completion of a collaboration with TheraCann International involving the integration of DNA technology into the global cannabis supply chain. The company has also made advancements in securing global supply chains, providing solutions to combat counterfeit products, protect valuable assets, and prevent theft. Applied DNA Sciences Inc has expanded its scope by collaborating with various sectors including textiles, pharmaceuticals, and defense. Moreover, the company has received multiple awards and recognition for its innovative anti-counterfeiting technology. Overall, Applied DNA Sciences Inc continues to make strides in enabling secure, traceable, and transparent supply chains across industries.

What is the history and background of the company Applied DNA Sciences?

Applied DNA Sciences Inc is a leading provider of DNA-based technology solutions for supply chain security, anti-counterfeiting, and anti-theft applications. Established in 1983, Applied DNA Sciences Inc has a rich history in developing innovative DNA-based authentication and security solutions. The company utilizes its proprietary SigNature DNA platform to create unique DNA markers that can be applied to a wide range of products. These markers can be used to verify the authenticity and origin of products, ensuring supply chain integrity and protecting against counterfeiting. Applied DNA Sciences Inc has a strong track record of working with various industries, including textiles, pharmaceuticals, and electronics, providing them with robust solutions to combat illicit activities.

Who are the main competitors of Applied DNA Sciences in the market?

The main competitors of Applied DNA Sciences Inc in the market are Thermo Fisher Scientific Inc, Illumina Inc, and Eurofins Scientific SE.

In which industries is Applied DNA Sciences primarily active?

Applied DNA Sciences Inc is primarily active in the industries of textile manufacturing, supply chain security, and anti-counterfeiting.

What is the business model of Applied DNA Sciences?

The business model of Applied DNA Sciences Inc involves providing molecular-based security and authentication solutions to industries including textiles, pharmaceuticals, automotive, electronics, and more. The company utilizes DNA-based tagging and authentication technologies to ensure the integrity and traceability of products, as well as to combat counterfeiting and fraud. Applied DNA Sciences offers a range of innovative solutions such as DNA marking, DNA authentication, and supply chain traceability. By leveraging its expertise in DNA-based technology, the company aims to protect brands, increase transparency in supply chains, and provide assurance to consumers that the products they purchase are genuine and safe.

Applied DNA Sciences 2024의 P/E 비율은 얼마입니까?

Applied DNA Sciences의 P/E 비율은 -0입니다.

Applied DNA Sciences 2024의 KUV는 얼마입니까?

Applied DNA Sciences의 P/S 비율은 0.04입니다.

Applied DNA Sciences의 AlleAktien 품질 점수는 얼마인가요?

Applied DNA Sciences에 대한 AlleAktien 품질 점수는 4/10입니다.

Applied DNA Sciences 2024의 매출은 얼마인가요?

예상되는 Applied DNA Sciences 매출은 3.59 백만 USD입니다.

Applied DNA Sciences 2024의 이익은 얼마인가요?

예상되는 Applied DNA Sciences 이익은 -72.7 백만 USD입니다.

Applied DNA Sciences은 무엇을 하나요?

Applied DNA Sciences Inc is a company that specializes in the development and application of DNA technologies. Its business model is based on providing customized DNA solutions to customers in various industries. One of the main divisions of Applied DNA Sciences is DNA-based authentication technology. Customers in textiles, security, pharmaceuticals, and agriculture can use this technology to secure products, processes, or supply chains. By marking products or packaging with a "DNA tag," customers can verify the authenticity of the products and prevent counterfeiting or fraud. This technology is also used in the pharmaceutical industry to combat counterfeit drugs and ensure patient safety. Another division of Applied DNA Sciences is DNA technology for the identification of individuals and animals. This includes DNA identification of animals in agriculture and pets, as well as the identification of individuals to prevent identity theft. This technology can also be used in forensics to convict criminals and identify victims. Another business field of Applied DNA Sciences is DNA-based anti-counterfeiting technology to prevent product counterfeiting. This technology can be used in various industries, such as combating counterfeit luxury goods and counterfeit auto parts in the automotive industry. Applied DNA Sciences Inc also offers DNA products, including the Synthetic DNA Armed Forces Platform (SigNature® DNA) and the molecular tagging system (taggants). SigNature DNA is a unique DNA signature system designed to protect products and identify criminals, while taggants were specifically developed for the Authentic-Secure series of security labels. In addition to these divisions, Applied DNA Sciences also develops advanced DNA methods and technologies for the detection of biological threats. These technologies have been developed to respond to biological threats such as viruses and bacteria and can be used in various applications, including healthcare, food safety, and environmental monitoring. In conclusion, Applied DNA Sciences Inc is a company with a wide portfolio of DNA-based solutions. The company offers various technologies to help customers in different industries secure their products, supply chains, and processes. The wide range of solutions allows Applied DNA Sciences to position itself in various industries and establish itself as a key player in the DNA industry.

Applied DNA Sciences 배당금은 얼마입니까?

Applied DNA Sciences은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

Applied DNA Sciences이 얼마나 자주 배당을 지급하나요?

Applied DNA Sciences의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Applied DNA Sciences ISIN이 무엇입니까?

Applied DNA Sciences의 ISIN은 US03815U3005입니다.

Applied DNA Sciences WKN은 무엇인가요?

Applied DNA Sciences의 WKN은 A2PUTA입니다.

Applied DNA Sciences 티커는 무엇인가요?

Applied DNA Sciences의 티커는 APDN입니다.

Applied DNA Sciences이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Applied DNA Sciences은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Applied DNA Sciences은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

Applied DNA Sciences의 배당 수익률은 얼마입니까?

Applied DNA Sciences의 현재 배당 수익률은 입니다.

Applied DNA Sciences의 배당금은 언제 지급되나요?

Applied DNA Sciences은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Applied DNA Sciences의 배당금은 얼마나 안전한가요?

Applied DNA Sciences은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

Applied DNA Sciences의 배당금은 얼마입니까?

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Applied DNA Sciences이(가) 속해 있는 섹터는 어디인가요?

Applied DNA Sciences은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Applied DNA Sciences kaufen, um die vorherige Dividende zu erhalten?

Applied DNA Sciences의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Applied DNA Sciences의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Applied DNA Sciences의 2023년도 배당금은 얼마였습니까?

2023년에 Applied DNA Sciences는 0 USD를 배당금으로 지급했습니다.

Applied DNA Sciences는 어떤 화폐로 배당금을 지급하나요?

Applied DNA Sciences의 배당금은 USD에 지급됩니다.

증권거래소	Applied DNA Sciences 티커
뒤셀도르프	UDJP.DU
프랑크푸르트	UDJP.F
뮌헨	UDJP.MU
NASDAQ	APDN

Applied DNA Sciences 티커	Applied DNA Sciences FIGI
APDN:US	BBG000DGRCY6
APDN:UA	BBG000DGSFQ7
APDN:UC	BBG000DGSG49
APDN:UN	BBG000DGSGV9
APDN:UP	BBG000DGSH65
APDN:UB	BBG000DGSJ25
APDN:UM	BBG000DGSK13
APDN:UX	BBG000DGSKK2
APDN:UR	BBG000DGSKZ6
APDN:UD	BBG000DGSNJ8
APDN:UF	BBG000DGSR90
APDN:VY	BBG000DGSRQ1
APDN:VJ	BBG000DGSRY2
APDN:VK	BBG000DGSSF1
UDJP:GR	BBG000HTKMR7
UDJP:GF	BBG000HTKNB2
UDJP:GD	BBG000HTKNQ6
UDJP:GS	BBG000HTKQG0
UDJP:GM	BBG000HTKQX1
UDJP:GB	BBG000HTKRG8
APDN:VF	BBG00DJF4VJ4
APDNUSD:XH	BBG00JVYHDM8
APDNUSD:XF	BBG00JVYHDP5
APDNUSD:XE	BBG00JVYHDR3
APDNUSD:XL	BBG00JVYHDT1
APDNUSD:XG	BBG00JVYHDV8
APDNUSD:XO	BBG00JVYHDW7
APDNUSD:XA	BBG00JVYHF16
APDNUSD:XT	BBG00JVYHF34
APDNUSD:XW	BBG00JVYHF43
APDNUSD:XU	BBG00JVYHF52
APDNUSD:XV	BBG00JVYHF61
APDNUSD:XM	BBG00JVYHF70
APDNUSD:EU	BBG00JVYHFF1
UDJP:GZ	BBG00QRWSJ19
APDNEUR:XH	BBG00QRZSQ07
APDNEUR:XF	BBG00QRZSQ25
APDNEUR:XE	BBG00QRZSQ43
APDNEUR:XJ	BBG00QRZSQ52
APDNEUR:XL	BBG00QRZSQ61
APDNEUR:XG	BBG00QRZSQ70
APDNEUR:XO	BBG00QRZSQ89
APDNEUR:XA	BBG00QRZSQD3
APDNEUR:XW	BBG00QRZSQH9
APDNEUR:XU	BBG00QRZSQJ7
APDNEUR:XV	BBG00QRZSQL4
APDNEUR:XM	BBG00QRZSQM3
APDNEUR:XQ	BBG00QRZSQN2
APDNEUR:XX	BBG00QRZSQP0
APDNEUR:XZ	BBG00QRZSQQ9
APDNEUR:X1	BBG00QRZSQS7
APDNEUR:EP	BBG00QS6HDJ1
APDNEUR:EZ	BBG00QS6HDL8
APDNGBP:EP	BBG00QTZ5F77
APDNGBP:EZ	BBG00QTZ5FD0
APDNGBP:XS	BBG00QTZ5FJ4
APDNGBP:X2	BBG00QTZ5FK2
APDNGBP:XH	BBG00QTZ5FM0
APDNGBP:XF	BBG00QTZ5FP7
APDNGBP:XE	BBG00QTZ5FR5
APDNGBP:XJ	BBG00QTZ5FS4
APDNGBP:XL	BBG00QTZ5FT3
APDNGBP:XG	BBG00QTZ5FV0
APDNGBP:XO	BBG00QTZ5FW9
APDNGBP:XA	BBG00QTZ5G02
APDNGBP:E1	BBG00QTZ5G11
APDNGBP:XT	BBG00QTZ5G20
APDNGBP:XW	BBG00QTZ5G39
APDNGBP:XU	BBG00QTZ5G48
APDNGBP:XV	BBG00QTZ5G66
APDNGBP:XM	BBG00QTZ5G75
APDNGBP:XQ	BBG00QTZ5G84
APDNGBP:XX	BBG00QTZ5G93
APDNGBP:XZ	BBG00QTZ5GB0
APDNGBP:X1	BBG00QTZ5GD8
APDNGBP:EU	BBG00QTZ5GG5
UDJP:TH	BBG00S4WYP19
UDJP:QT	BBG00S5FLD89
APDN:VG	BBG00X1MH1Z8
APDN:VP	BBG00X1QXBV3
UDJP:LA	BBG018H8FN17
UDJP:LU	BBG018J22QL3

2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e
0	0	0	0	0	0	0	0	1	2	2	9	4	4	3	5	1	9	18	13	3	5
-	-	-	-	-	-	-	-	-	100.00	-	350.00	-55.56	-	-25.00	66.67	-80.00	800.00	100.00	-27.78	-76.92	66.67
-	-	-	-	-	-	-	-	500.00	250.00	250.00	55.56	75.00	75.00	66.67	80.00	100.00	44.44	27.78	38.46	166.67	100.00
0	0	0	0	0	0	0	0	0	0	0	0	3	3	2	4	1	4	5	5	0	0
-19	-67	-2	-13	-6	3	-7	-10	-7	-17	-13	-11	-12	-12	-11	-8	-13	-14	-8	-9	-72	-10
-	252.63	-97.01	550.00	-53.85	-150.00	-333.33	42.86	-30.00	142.86	-23.53	-15.38	9.09	-	-8.33	-27.27	62.50	7.69	-42.86	12.50	700.00	-86.11
0	1	2	3	4	6	6	8	12	15	17	24	30	33	37	46	196	346	448	654	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

한 눈에 저평가된 주식을 인식하세요

가격

가격

티커APDN

ISINUS03815U3005

WKNA2PUTA

Applied DNA Sciences 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Applied DNA Sciences 주가 이력

Applied DNA Sciences 주식 매출, EBIT, 이익 US03815U3005 · A2PUTA

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Applied DNA Sciences 매출, 이익 및 EBIT 역사

Applied DNA Sciences 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Applied DNA Sciences 주식 마진 US03815U3005 · A2PUTA

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Applied DNA Sciences 마진 역사

Applied DNA Sciences 주식 매출, EBIT, 주당 순이익 US03815U3005 · A2PUTA

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Applied DNA Sciences 매출, 이익 및 EBIT 주당 역사

Applied DNA Sciences 주식 및 주식 분석

Applied DNA Sciences 매출 세분화 US03815U3005 · A2PUTA

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

Applied DNA Sciences 매출 세분화

Applied DNA Sciences 지역별 매출 US03815U3005 · A2PUTA

세그먼트별 매출

지역별 매출 개요

해석 및 사용법

투자 전략

Applied DNA Sciences 매출 세분화

한눈에 과소평가된 주식을 인식하세요.

Applied DNA Sciences Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Applied DNA Sciences 역사적인 P/E, EBIT 및 P/S에 따른 평가

한눈에 과소평가된 주식을 인식하세요.

Applied DNA Sciences 주식 수량 US03815U3005 · A2PUTA

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

티커
APDN

ISIN
US03815U3005

WKN
A2PUTA